APOB and steatosis: This variation may not point to the different effects of the insulin-resistant state in NAFLD patients with different body mass indexes, although insulin resistance has been identified as one of the important factors of steatosis progression for driving overproduction of liver ApoB and related cholesterol (27, 28).